StopDown
Acquisition · 11 August 2026Redcliffe LabsOmnichannel diagnostic service providerredcliffelabs.com ↗

Redcliffe Labs acquires Megavision Diagnostics for ₹40 crore

By · Editor ·

Noida
  • Redcliffe Labs is an omnichannel diagnostic service provider headquartered in Noida
  • It acquired Pune-based Megavision Diagnostics Center for approximately ₹40 crore, adding two MRI-equipped centres
  • The acquisition is part of Redcliffe's strategy to expand integrated diagnostics across Western India

What happened

  • Redcliffe Labs has acquired Megavision Diagnostics Center in Pune for approximately ₹40 crore.
  • Megavision runs two MRI-equipped centres in Pune's Pimpri-Chinchwad area and has served the region for over two decades.
  • The acquisition adds advanced imaging (MRI) capabilities to Redcliffe's pathology network.
  • Redcliffe retains Megavision's entire workforce.
  • Founder and director Dr Kedar Prabhakar Bhate continues to lead the business as Megavision Redcliffe Labs.
  • Dr Bhate will work with Redcliffe's Clinical Board to strengthen radiology services.
  • Redcliffe did not disclose the purchase price in its formal announcement.

Why it matters

  • The acquisition comes amid consolidation in India's diagnostics sector in 2026.
  • In May 2026, Dr Lal PathLabs acquired Shahbazkers Diagnostic Centre for up to ₹20 crore.
  • Also in May 2026, MedGenome acquired a majority stake in Siddhi Diagnostics & Research Centre.
  • Neuberg Diagnostics acquired a controlling stake in NM Medical (18 centres across Mumbai, Pune, Bengaluru).
  • Diagnostic players are moving towards integrated platforms combining pathology, radiology, imaging, genomics, and preventive healthcare.

The business

  • Redcliffe Labs is an omnichannel diagnostic service provider headquartered in Noida.
  • It offers pathology, radiology, imaging, genomics (GeneCliffe), and preventive healthcare packages.
  • Redcliffe provides home sample collection, temperature-controlled sample transport, and doctor-verified smart reports.
  • It has a she-centric diagnostic platform called Femcliffe.
  • Redcliffe has served more than 1 crore customers to date.
  • It operates across more than 220 cities with over 80 owned laboratories.
  • Its network covers more than 4,000 pincodes and offers more than 3,600 diagnostic tests.
  • Redcliffe has 1,500+ trained phlebotomists and 2,000+ collection centres.

The founders

Aditya Kandoi

Founder & CEO
in

Dheeraj Jain

Chairman & Founder

In numbers

₹40 croreAcquisition value · 2026
1 crore+Customers served to date · 2026
220+Cities of operation · 2026
80+Owned laboratories · 2026
4,000+Pincodes covered · 2026
3,600+Diagnostic tests offered · 2026
1,500+Trained phlebotomists · 2026
2,000+Collection centres · 2026

What happens next

  • Redcliffe plans to use partnerships and acquisitions to expand further across Western India.
  • The acquisition is part of Redcliffe's strategy to expand integrated diagnostics across Western India.

Earlier rounds

  • 2024-02 · acquisition
  • 2026-06 · acquisition

Up against

Dr Lal PathLabsMedGenomeNeuberg Diagnostics

Words to know

MRI
Magnetic Resonance Imaging, a medical imaging technique used to create detailed pictures of organs and tissues inside the body.
Omnichannel
A business approach that provides a seamless customer experience across multiple channels, such as physical centres, online booking, and home collection.
Phlebotomist
A trained healthcare professional who draws blood from patients for medical testing.
Pincode
A postal code used in India to identify a specific geographic area for mail delivery.

The numbers around it

Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.

#The numbers around it
WhenRoundAmountLed by
17 September 2024Series C$42MIFU (Denmark's Investment Fund for Developing Countries)
13 August 2023growth$80 million
29 September 2022Series B$100-125 million
6 May 2022Series B$61MLeapFrog Investments

Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Mergers and acquisitions: An acquisition is when one company buys another, and a merger is when two companies combine into one. For most Indian startups a sale is a likelier exit than an IPO, and the Competition Commission of India (CCI) must approve deals that cross its asset, turnover or ₹2,000 crore deal-value limits.

Everything on Redcliffe Labs → · All startup news on 11 August 2026 →

Is this Redcliffe Labs? Get your “Featured on StopDown” badge →